mRNA Cancer Vaccines and Therapeutics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2017-2028)
2.2 mRNA Cancer Vaccines and Therapeutics Growth Trends by Region
2.2.1 mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 mRNA Cancer Vaccines and Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 mRNA Cancer Vaccines and Therapeutics Market Dynamics
2.3.1 mRNA Cancer Vaccines and Therapeutics Industry Trends
2.3.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
2.3.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
2.3.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue
3.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2017-2022)
3.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global mRNA Cancer Vaccines and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
3.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2021
3.5 mRNA Cancer Vaccines and Therapeutics Key Players Head office and Area Served
3.6 Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Type
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2023-2028)
5 mRNA Cancer Vaccines and Therapeutics Breakdown Data by Application
5.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size (2017-2028)
6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type
6.2.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022)
6.2.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028)
6.2.3 North America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2017-2028)
6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application
6.3.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022)
6.3.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028)
6.3.3 North America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2017-2028)
6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
6.4.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2017-2022)
6.4.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size (2017-2028)
7.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
7.2.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2017-2028)
7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application
7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2017-2028)
7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
7.4.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type
8.2.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application
8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
8.4.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size (2017-2028)
9.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type
9.2.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2017-2028)
9.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application
9.3.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2017-2028)
9.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country
9.4.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type
10.2.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application
10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
10.4.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Details
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.1.5 Moderna Therapeutics Recent Developments
11.2 CureVac
11.2.1 CureVac Company Details
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
11.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.2.5 CureVac Recent Developments
11.3 Translate Bio
11.3.1 Translate Bio Company Details
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
11.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.3.5 Translate Bio Recent Developments
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
11.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.4.5 BioNTech Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.5.5 Sangamo Therapeutics Recent Developments
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Details
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.6.5 Argos Therapeutics Recent Developments
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Details
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
11.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.7.5 In-Cell-Art Recent Developments
11.8 eTheRNA
11.8.1 eTheRNA Company Details
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
11.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.8.5 eTheRNA Recent Developments
11.9 Ethris
11.9.1 Ethris Company Details
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
11.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.9.5 Ethris Recent Developments
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Details
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
11.10.5 Tiba Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Adeno Carcinomas
Table 3. Key Players of Mucinous Carcinomas
Table 4. Key Players of Adenosquamous Carcinomas
Table 5. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global mRNA Cancer Vaccines and Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2017-2022)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region (2023-2028)
Table 11. mRNA Cancer Vaccines and Therapeutics Market Trends
Table 12. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 13. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 14. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 15. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Players (2017-2022)
Table 17. Global Top mRNA Cancer Vaccines and Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2021)
Table 18. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players mRNA Cancer Vaccines and Therapeutics Product Solution and Service
Table 22. Date of Enter into mRNA Cancer Vaccines and Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2017-2022)
Table 26. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2023-2028)
Table 28. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Application (2017-2022)
Table 30. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Application (2023-2028)
Table 32. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 62. Moderna Therapeutics Company Details
Table 63. Moderna Therapeutics Business Overview
Table 64. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 65. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 66. Moderna Therapeutics Recent Developments
Table 67. CureVac Company Details
Table 68. CureVac Business Overview
Table 69. CureVac mRNA Cancer Vaccines and Therapeutics Product
Table 70. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 71. CureVac Recent Developments
Table 72. Translate Bio Company Details
Table 73. Translate Bio Business Overview
Table 74. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
Table 75. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 76. Translate Bio Recent Developments
Table 77. BioNTech Company Details
Table 78. BioNTech Business Overview
Table 79. BioNTech mRNA Cancer Vaccines and Therapeutics Product
Table 80. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 81. BioNTech Recent Developments
Table 82. Sangamo Therapeutics Company Details
Table 83. Sangamo Therapeutics Business Overview
Table 84. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 85. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 86. Sangamo Therapeutics Recent Developments
Table 87. Argos Therapeutics Company Details
Table 88. Argos Therapeutics Business Overview
Table 89. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 90. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 91. Argos Therapeutics Recent Developments
Table 92. In-Cell-Art Company Details
Table 93. In-Cell-Art Business Overview
Table 94. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
Table 95. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 96. In-Cell-Art Recent Developments
Table 97. eTheRNA Company Details
Table 98. eTheRNA Business Overview
Table 99. eTheRNA mRNA Cancer Vaccines and Therapeutics Product
Table 100. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 101. eTheRNA Recent Developments
Table 102. Ethris Company Details
Table 103. Ethris Business Overview
Table 104. Ethris mRNA Cancer Vaccines and Therapeutics Product
Table 105. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 106. Ethris Recent Developments
Table 107. Tiba Biotechnology Company Details
Table 108. Tiba Biotechnology Business Overview
Table 109. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
Table 110. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2017-2022) & (US$ Million)
Table 111. Tiba Biotechnology Recent Developments
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Adeno Carcinomas Features
Figure 3. Mucinous Carcinomas Features
Figure 4. Adenosquamous Carcinomas Features
Figure 5. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2021 VS 2028
Figure 6. Infectious Disease Case Studies
Figure 7. Cancer Case Studies
Figure 8. Others Case Studies
Figure 9. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 10. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global mRNA Cancer Vaccines and Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Share by Region: 2021 VS 2028
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2021
Figure 14. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2021
Figure 16. North America mRNA Cancer Vaccines and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2017-2028)
Figure 18. North America mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2017-2028)
Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Size Share by Country (2017-2028)
Figure 20. United States mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe mRNA Cancer Vaccines and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2017-2028)
Figure 24. Europe mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2017-2028)
Figure 25. Europe mRNA Cancer Vaccines and Therapeutics Market Size Share by Country (2017-2028)
Figure 26. Germany mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific mRNA Cancer Vaccines and Therapeutics Market Size Share by Region (2017-2028)
Figure 36. China mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America mRNA Cancer Vaccines and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2017-2028)
Figure 44. Latin America mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2017-2028)
Figure 45. Latin America mRNA Cancer Vaccines and Therapeutics Market Size Share by Country (2017-2028)
Figure 46. Mexico mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa mRNA Cancer Vaccines and Therapeutics Market Size Share by Country (2017-2028)
Figure 52. Turkey mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE mRNA Cancer Vaccines and Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 56. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 57. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 58. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 59. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 60. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 61. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 62. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 63. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 64. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Industry Market Size
